FDA Orphan Drug Designation Granted
The orphan drug designation will provide SFA Therapeutics with significant drug development and tax advantages as well as an expanded period of market exclusivity. Link to Press Release
Close
The orphan drug designation will provide SFA Therapeutics with significant drug development and tax advantages as well as an expanded period of market exclusivity. Link to Press Release
610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States
